{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T04:53:41Z","timestamp":1764132821521},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":578,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Dermatol"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1111\/ced.12261","type":"journal-article","created":{"date-parts":[[2014,1,31]],"date-time":"2014-01-31T04:53:59Z","timestamp":1391144039000},"page":"202-208","source":"Crossref","is-referenced-by-count":13,"title":["Inhibitory effects of imatinib mesylate on human epidermal melanocytes"],"prefix":"10.1093","volume":"39","author":[{"given":"Y.","family":"Wang","sequence":"first","affiliation":[{"name":"Bone Marrow Transplantation Center; The First Affiliated Hospital; Zhejiang University School of Medicine; Zhejiang China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Zhao","sequence":"additional","affiliation":[{"name":"Bone Marrow Transplantation Center; The First Affiliated Hospital; Zhejiang University School of Medicine; Zhejiang China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Liu","sequence":"additional","affiliation":[{"name":"Bone Marrow Transplantation Center; The First Affiliated Hospital; Zhejiang University School of Medicine; Zhejiang China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Zhang","sequence":"additional","affiliation":[{"name":"Bone Marrow Transplantation Center; The First Affiliated Hospital; Zhejiang University School of Medicine; Zhejiang China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Xiao","sequence":"additional","affiliation":[{"name":"Bone Marrow Transplantation Center; The First Affiliated Hospital; Zhejiang University School of Medicine; Zhejiang China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Wu","sequence":"additional","affiliation":[{"name":"Bone Marrow Transplantation Center; The First Affiliated Hospital; Zhejiang University School of Medicine; Zhejiang China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Xu","sequence":"additional","affiliation":[{"name":"Bone Marrow Transplantation Center; The First Affiliated Hospital; Zhejiang University School of Medicine; Zhejiang China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Hu","sequence":"additional","affiliation":[{"name":"Bone Marrow Transplantation Center; The First Affiliated Hospital; Zhejiang University School of Medicine; Zhejiang China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Fu","sequence":"additional","affiliation":[{"name":"Bone Marrow Transplantation Center; The First Affiliated Hospital; Zhejiang University School of Medicine; Zhejiang China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Cao","sequence":"additional","affiliation":[{"name":"Bone Marrow Transplantation Center; The First Affiliated Hospital; Zhejiang University School of Medicine; Zhejiang China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Luo","sequence":"additional","affiliation":[{"name":"Bone Marrow Transplantation Center; The First Affiliated Hospital; Zhejiang University School of Medicine; Zhejiang China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Huang","sequence":"additional","affiliation":[{"name":"Bone Marrow Transplantation Center; The First Affiliated Hospital; Zhejiang University School of Medicine; Zhejiang China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2014,1,31]]},"reference":[{"key":"10.1111\/ced.12261-BIB0001|ced12261-cit-0001","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1056\/NEJM200104053441401","article-title":"Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia","volume":"344","author":"Druker","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1111\/ced.12261-BIB0002|ced12261-cit-0002","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1056\/NEJMct071828","article-title":"BCR-ABL tyrosine kinase inhibitors for chronic myelogenous leukemia","volume":"357","author":"Schiffer","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1111\/ced.12261-BIB0003|ced12261-cit-0003","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1002\/cncr.20267","article-title":"Imatinib mesylate causes hypopigmentation in the skin","volume":"100","author":"Leong","year":"2004","journal-title":"Cancer"},{"key":"10.1111\/ced.12261-BIB0004|ced12261-cit-0004","first-page":"291","article-title":"Imatinib mesylate in chronic myeloid leukemia: a prospective, single arm, non-randomized study","volume":"53","author":"Deshmukh","year":"2005","journal-title":"J Assoc Physicians India"},{"key":"10.1111\/ced.12261-BIB0005|ced12261-cit-0005","doi-asserted-by":"crossref","first-page":"45","DOI":"10.4103\/0378-6323.13788","article-title":"Generalized hypopigmentation due to imatinib: a fairness boon?","volume":"71","author":"Sharma","year":"2005","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1111\/ced.12261-BIB0006|ced12261-cit-0006","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S1658-3876(09)50026-X","article-title":"Hypopigmentation of the skin due to imatinib mesylate in patients with chronic myeloid leukemia","volume":"2","author":"Aleem","year":"2009","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"10.1111\/ced.12261-BIB0007|ced12261-cit-0007","first-page":"2","article-title":"Clinical characteristics and hematologic responses to imatinib in patients with chronic phase myeloid leukemia (CML) at Cipto Mangunkusumo Hospital","volume":"42","author":"Reksodiputro","year":"2010","journal-title":"Acta Med Indones"},{"key":"10.1111\/ced.12261-BIB0008|ced12261-cit-0008","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s12185-009-0292-7","article-title":"Efficacy and prognosis of chronic myeloid leukemia treated with imatinib mesylate in a Chinese population","volume":"89","author":"Zhao","year":"2009","journal-title":"Int J Hematol"},{"key":"10.1111\/ced.12261-BIB0009|ced12261-cit-0009","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1365-2133.2006.07359.x","article-title":"Imatinib mesilate inhibits melanogenesis in vitro","volume":"155","author":"Cario-Andre","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1111\/ced.12261-BIB0010|ced12261-cit-0010","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1056\/NEJMra013339","article-title":"Imatinib mesylate-a new oral targeted therapy","volume":"346","author":"Savage","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1111\/ced.12261-BIB0011|ced12261-cit-0011","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/dvdy.20340","article-title":"Cooperative and indispensable roles of endothelin 3 and KIT signalings in melanocyte development","volume":"233","author":"Aoki","year":"2005","journal-title":"Dev Dyn"},{"key":"10.1111\/ced.12261-BIB0012|ced12261-cit-0012","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1001\/archdermatol.2009.263","article-title":"Disappearance of lentigines in a patient receiving imatinib treatment for familial gastrointestinal stromal tumor syndrome","volume":"145","author":"Campbell","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1111\/ced.12261-BIB0013|ced12261-cit-0013","first-page":"1062","article-title":"Pigmentary changes in a patient treated with imatinib","volume":"10","author":"Balagula","year":"2011","journal-title":"J Drugs Dermatol"},{"key":"10.1111\/ced.12261-BIB0014|ced12261-cit-0014","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1002\/cncr.11812","article-title":"Imatinib mesylate causes hypopigmentation in the skin","volume":"98","author":"Tsao","year":"2003","journal-title":"Cancer"},{"key":"10.1111\/ced.12261-BIB0015|ced12261-cit-0015","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/j.1365-2141.2005.05431.x","article-title":"Loss of skin pigment caused by imatinib therapy","volume":"129","author":"McPartlin","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1111\/ced.12261-BIB0016|ced12261-cit-0016","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.1182\/blood-2006-07-036012","article-title":"Trough imatinib plasma levels are associated with both cytogenetic and molecular responses to standard-dose imatinib in chronic myeloid leukemia","volume":"109","author":"Picard","year":"2007","journal-title":"Blood"},{"key":"10.1111\/ced.12261-BIB0017|ced12261-cit-0017","doi-asserted-by":"crossref","first-page":"4022","DOI":"10.1182\/blood-2007-10-116475","article-title":"Imatinib pharmacokinetics and its correlation with response and safety in chronic-phase chronic myeloid leukemia: a subanalysis of the IRIS study","volume":"111","author":"Larson","year":"2008","journal-title":"Blood"},{"key":"10.1111\/ced.12261-BIB0018|ced12261-cit-0018","first-page":"625","article-title":"Alpha1 acid glycoprotein binds to imatinib (STI571) and substantially alters its pharmacokinetics in chronic myeloid leukemia patients","volume":"9","author":"Gambacorti-Passerini","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1111\/ced.12261-BIB0019|ced12261-cit-0019","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nature05660","article-title":"Melanocyte biology and skin pigmentation","volume":"445","author":"Lin","year":"2007","journal-title":"Nature"},{"key":"10.1111\/ced.12261-BIB0020|ced12261-cit-0020","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1046\/j.1523-1747.2001.01290.x","article-title":"The paracrine role of stem cell factor\/c-kit signaling in the activation of human melanocytes in ultraviolet-B-induced pigmentation","volume":"116","author":"Hachiya","year":"2001","journal-title":"J Invest Dermatol"},{"key":"10.1111\/ced.12261-BIB0021|ced12261-cit-0021","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1034\/j.1600-0749.2003.00055.x","article-title":"The role of Kit-ligand in melanocyte development and epidermal homeostasis","volume":"16","author":"Wehrle-Haller","year":"2003","journal-title":"Pigment Cell Res"},{"key":"10.1111\/ced.12261-BIB0022|ced12261-cit-0022","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/34681","article-title":"MAP kinase links the transcription factor Microphthalmia to c-Kit signalling in melanocytes","volume":"391","author":"Hemesath","year":"1998","journal-title":"Nature"},{"key":"10.1111\/ced.12261-BIB0023|ced12261-cit-0023","doi-asserted-by":"crossref","first-page":"9966","DOI":"10.1074\/jbc.273.16.9966","article-title":"Inhibition of the mitogen-activated protein kinase pathway triggers B16 melanoma cell differentiation","volume":"273","author":"Englaro","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1111\/ced.12261-BIB0024|ced12261-cit-0024","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1034\/j.1600-0749.2003.00029.x","article-title":"Chemical and instrumental approaches to treat hyperpigmentation","volume":"16","author":"Briganti","year":"2003","journal-title":"Pigment Cell Res"},{"key":"10.1111\/ced.12261-BIB0025|ced12261-cit-0025","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/ptr.2928","article-title":"Screening of Kit inhibitors: suppression of Kit signaling and melanogenesis by emodin","volume":"24","author":"Lee","year":"2010","journal-title":"Phytother Res"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fced.12261","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/ced.12261\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T09:38:47Z","timestamp":1676367527000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/39\/2\/202\/6621114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,31]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,3]]}},"URL":"https:\/\/doi.org\/10.1111\/ced.12261","relation":{},"ISSN":["0307-6938"],"issn-type":[{"value":"0307-6938","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1,31]]}}}